<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba8/6944038/1a91206578d6/amjcaserep-20-1923-g003.jpg"/> </div> <div class="text-side"> <h1>Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report.</h1> <p>Microscopic low- and high-power views (A) Tumor composed of nodules separated by fibrous septa (H&amp;E 40×). (B) Areas of spindle cell morphology with extravasated red blood cells (arrow) resembling Kaposi sarcoma (H&amp;E 400×). (C) Characteristic glomeruloid structures formed by tumor cells (arrows) (H&amp;E 200×) (D) Intratumoral hemorrhage forming hemosiderin (arrow) (H&amp;E 400×). (E, F) Low power and high power views showed a D2–40 immunostaining positivity in the peripheral areas of capillary proliferation (characteristic pattern of KHE). H&amp;E – hematoxylin and eosin; KHE – kaposiform hemangioendothelioma.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31866667/" target="_blank">31866667</a></p><p>Type: Premalignant/Malignant, Category: Vascular</p>
</div> </div></div></body></html>